Autoregulation of 5-fluorouracil metabolism

This publication has 26 references indexed in Scilit:

• Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours
  British Journal of Cancer, 1998
• Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.
  Journal of Clinical Investigation, 1996
• Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population
  British Journal of Clinical Pharmacology, 1996
• Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU
  Cancer, 1996
• Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency
  Trends in Pharmacological Sciences, 1995
• Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancer
  Clinical Pharmacology & Therapeutics, 1994
• Role of Dihydropyrimidine Dehydrogenase in the Uridine Nucleotide Metabolism in the Rat Liver.
  Journal of Nutritional Science and Vitaminology, 1992
• Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome
  Cancer, 1991
• Clinical Pharmacology of 5-Fluorouracil
  Clinical Pharmacokinetics, 1989
• Circadian rhythm of rat liver dihydropyrimidine dehydrogenase
  Biochemical Pharmacology, 1988